(Q42582524)

3 November 2017

Relaxin reduces fibrosis in models of progressive and established hepatic fibrosis (English)

1 reference

3 November 2017

Robert G Bennett

1

1 reference

3 November 2017

Dean G Heimann

series ordinal

2

1 reference

3 November 2017

Dean J Tuma

series ordinal

3

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

Annals of the New York Academy of Sciences

3 November 2017

1 reference

3 November 2017

1160

1 reference

3 November 2017

348-349

1 reference

Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo

3 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716062

PubMed Central

reference URL

Inhibition of markers of hepatic stellate cell activation by the hormone relaxin

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2716062

PubMed Central

reference URL

Relaxin receptors in hepatic stellate cells and cirrhotic liver

16 August 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/19416217

PubMed

reference URL

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1749-6632.2008.03783.X

1 reference

3 November 2017

1 reference

3 November 2017

PubMed publication ID

19416217

1 reference